Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

Consumer Defensive Household & Personal Products Cannabis
NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci’s neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci’s IP can be applied to many different categories in the beverage, food, and nutraceutical space.


TSXV:NU.H - Post by User

NeutriSci International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by JRSDIRECTon Feb 22, 2018 9:06am
118 Views
Post# 27600486

NeutriSci Named to the 2018 TSX Venture 50

NeutriSci Named to the 2018 TSX Venture 50

Posted on TMX Money

VANCOUVER, B.C., Feb. 22, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) is pleased to announce it has been named to the 2018 TSX Venture 50®, an annual ranking of top-performing companies on the TSX Venture Exchange over the last year, ranking 10th overall.

Each year, the TSX Venture 50® ranking showcases listed companies that have shown notable results in key measures of market performance. The companies included in the 2018 TSX Venture 50® were selected based on three equally weighted criteria: market capitalization growth, share price appreciation and trading volume.

Glen Rehman, CEO of NeutriSci, stated: "We are pleased to report that NeutriSci has placed as one of the top life sciences companies selected for the 2018 TSX Venture 50.  This recognition serves to validate the Company's strategic execution in 2017. We anticipate extending that same strategy into 2018 by expanding distribution both domestically and globally."

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.
Glen Rehman
President/CEO
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities